about
Structure, evolution, and biology of the MUC4 mucinMucins and toll-like receptors: kith and kin in infection and cancerProtRepeatsDB: a database of amino acid repeats in genomes.Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium.Current status of mucins in the diagnosis and therapy of cancer.Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese malesSecreted phosphoprotein 1 is a determinant of lung function development in mice.Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitroGenetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population.Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice.Shared Risk Factors in Cardiovascular Disease and Cancer.Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.Acrolein - a pulmonary hazard.Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease.Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.6-Mercaptopurine reduces cytokine and Muc5ac expression involving inhibition of NFκB activation in airway epithelial cells.Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells.Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro.Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.
P2860
Q24630985-B29B3B7B-9EDE-4250-ABA6-0D1F5991890CQ26830597-CD047059-EBB9-469E-BFF2-30F1D1EE46A4Q33249306-B83155D1-5FF7-483D-9EC8-6405E8470831Q33339025-5A6D0C2A-C903-49B5-A755-B1537EF2D1CCQ33757326-EB80B570-5A8F-49FA-9D12-F3C88FE60182Q34046860-BBDB14E9-C5F3-42FA-AD4E-67C8F85DE429Q34471236-D3BFB6C9-3EE1-4C00-9DDA-7C2852E9551FQ34703319-C45B1B74-A795-418E-9522-6D58973CA75AQ35035530-37ACC9AF-D6CD-447D-A423-089F3B7564B7Q35790324-2759607F-B759-4520-86E9-3E9B24908A32Q36579793-BEB95F58-B8C5-4058-98B5-24E6DD866E87Q36709155-489F0EDF-6E3E-4643-8DB4-018F272CD59BQ36891496-E7F7C6AA-618E-47B3-943F-DCE1A0FD4168Q37945138-CC285B6C-33CE-4664-8F17-810490E3659BQ38023560-4E544377-0362-47CD-A1B7-98B808CCE183Q38560347-0BA7A5B9-3474-4ABB-B82D-DD1215460A60Q38862899-C5BFCC1E-E502-4454-A819-A96749BE5991Q41922735-F9C1782B-E138-4B85-8EB6-BA3BE6C939C0Q43087484-E667EF12-691E-421A-96D3-E8A2D8A87CD3Q44258837-2E10B1BA-BAD5-4A0A-842C-3E683A61CA0BQ44519283-803FFE5A-DFB2-4242-8EC6-FA8F08769A4CQ44892855-68D2C899-F709-45E7-B70D-026DB0CC40ACQ47318066-9E13817A-5C9E-48DC-B233-445E44D8082C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mucin apoprotein expression in COPD.
@ast
Mucin apoprotein expression in COPD.
@en
Mucin apoprotein expression in COPD.
@nl
type
label
Mucin apoprotein expression in COPD.
@ast
Mucin apoprotein expression in COPD.
@en
Mucin apoprotein expression in COPD.
@nl
prefLabel
Mucin apoprotein expression in COPD.
@ast
Mucin apoprotein expression in COPD.
@en
Mucin apoprotein expression in COPD.
@nl
P2093
P1433
P1476
Mucin apoprotein expression in COPD
@en
P2093
Daniel R Prows
Leigh G Simpson
Michael T Borchers
P304
P356
10.1378/CHEST.121.5_SUPPL.166S
P407
P433
P577
2002-05-01T00:00:00Z